We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEL
851
DELISTED
American Equity Investment Life Holding Company
AEL
| $7.67M | 0.02% |
274,451
+46,787
| +21% | +$1.5M |
|
|
TCO
852
DELISTED
Taubman Centers Inc.
TCO
| $7.67M | 0.02% |
168,568
+46,174
| +38% | +$2.42M |
|
853
Ionis Pharmaceuticals
IONS
$9.06B
| $7.66M | 0.02% |
141,776
-5,337
| -4% | -$272K |
|
854
Sprouts Farmers Market
SFM
$8.28B
| $7.66M | 0.02% |
325,789
+69,423
| +27% | +$1.81M |
|
855
Emergent Biosolutions
EBS
$382M
| $7.63M | 0.02% |
128,755
+24,354
| +23% | +$1.57M |
|
|
PRSP
856
DELISTED
Perspecta Inc. Common Stock
PRSP
| $7.61M | 0.02% |
442,007
+160,578
| +57% | +$3.56M |
|
857
TechnipFMC
FTI
$27.1B
| $7.58M | 0.02% |
520,414
+4,983
| +1% | +$92.7K |
|
858
VICI Properties
VICI
$29.2B
| $7.58M | 0.02% |
403,452
+45,275
| +13% | +$952K |
|
859
Etsy
ETSY
$7.89B
| $7.57M | 0.02% |
159,084
+50,916
| +47% | +$2.4M |
|
|
CMD
860
DELISTED
Cantel Medical Corporation
CMD
| $7.57M | 0.02% |
101,612
+21,175
| +26% | +$1.75M |
|
861
Agree Realty
ADC
$9.57B
| $7.54M | 0.02% |
127,541
+25,221
| +25% | +$1.44M |
|
|
SYNH
862
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $7.53M | 0.02% |
191,421
+77,875
| +69% | +$3.62M |
|
863
FTI Consulting
FCN
$4.37B
| $7.53M | 0.02% |
112,941
+19,326
| +21% | +$1.3M |
|
864
AMN Healthcare
AMN
$1.28B
| $7.52M | 0.02% |
132,770
+23,315
| +21% | +$1.31M |
|
865
The GEO Group
GEO
$4.19B
| $7.5M | 0.02% |
380,891
+143,724
| +61% | +$3.26M |
|
|
FNSR
866
DELISTED
Finisar Corp
FNSR
| $7.5M | 0.02% |
346,978
+64,874
| +23% | +$1.29M |
|
867
Keurig Dr Pepper
KDP
$42.1B
| $7.49M | 0.02% |
292,199
-7,974
| -3% | -$203K |
|
868
Sarepta Therapeutics
SRPT
$1.68B
| $7.42M | 0.02% |
68,037
-230
| -0.3% | -$28.8K |
|
869
News Corp Class A
NWSA
$15.1B
| $7.42M | 0.02% |
653,635
-11,978
| -2% | -$153K |
|
870
Murphy USA
MUSA
$10.9B
| $7.39M | 0.02% |
96,372
+35,734
| +59% | +$2.82M |
|
|
AXON
871
Axon Enterprise
AXON
$46.4B
| $7.38M | 0.02% |
168,675
+30,280
| +22% | +$1.57M |
|
872
ON Semiconductor
ON
$31.3B
| $7.38M | 0.02% |
446,953
-24,961
| -5% | -$432K |
|
873
Erie Indemnity
ERIE
$12.4B
| $7.38M | 0.02% |
55,322
-3,354
| -6% | -$435K |
|
874
Quanta Services
PWR
$102B
| $7.36M | 0.02% |
244,596
-11,478
| -4% | -$371K |
|
875
Dorman Products
DORM
$3.82B
| $7.34M | 0.02% |
81,500
+13,558
| +20% | +$1.08M |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.